Previous Article | Next Article ![]()
Applied and Environmental Microbiology, February 2004, p. 967-972, Vol. 70, No. 2
0099-2240/04/$08.00+0 DOI: 10.1128/AEM.70.2.967-972.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Department of Bioscience and Biotechnology, Drexel University, Philadelphia, Pennsylvania 19104
Received 3 November 2003/ Accepted 5 November 2003
|
|
|---|
|
|
|---|
The unicellular freshwater cyanobacterium Synechococcus elongatus has been used as a model organism for a number of genetic studies, including the identification of genes involved in photosynthetic gene expression and circadian rhythm (11, 12). This organism is amenable to molecular genetic analysis since it is naturally transformable with exogenous DNA, which allows the use of reporter gene fusions to study patterns of gene expression with the integration of such constructs into a chromosomal site (8, 9).
S. elongatus is an obligate photosynthetic prokaryote that carries out oxygenic-type photosynthesis. The photosystem II reaction center proteins, D1 and D2, are encoded by small gene families in this organism (7). Members of these gene families are differentially expressed in response to light intensity. The D2 protein is encoded by two genes, psbDI and psbDII. psbDI is expressed constitutively under all light intensities, while psbDII is induced at three- to fourfold greater levels under high-light conditions (5). Previous studies using translational and transcriptional reporter gene fusions have mapped regions of the psbDII untranslated leader region that are required for the expression of this gene under low- and high-light conditions (1, 5). This untranslated region (UTR) has been determined to contain three binding sites for protein factors that affect both high-light inducibility and level of expression from this promoter under low- and high-light regimes (1, 4). Binding site one (bs-1) is responsible for high-light induction of psbDII, while binding sites two and three (bs-2 and bs-3) are positive and negative regulatory elements, respectively (1).
We have designed a genetic selection scheme for Synechococcus species that facilitates the easy retrieval of mutations in a given signal transduction pathway. To test this scheme, we chose to use the high-light-regulated psbDII pathway in this organism. The basic premise of this scheme is that cyanobacterial strains where the psbDII high-light-induced signal transduction pathway is interrupted or malfunctional will not show an induction of psbDII expression in high light. This loss of psbDII induction in high light will be selected for by resistance to a toxic substrate, 5'-fluorocytosine. This chemical has been used previously as a marker in mammalian cells (10, 14). Conceptually, the cytosine deaminase selection scheme for mutant isolation should work as follows. Cells that possess an intact psbDII high-light-regulated pathway will induce the psbDII promoter under high-light conditions and express the codA gene and its protein product. This gene product (cytosine deaminase) will convert 5'-fluorocytosine to its toxic product, 5-fluorouracil, and will result in the death of all Synechococcus species cells that contain an intact psbDII high-light signal transduction pathway. Cells defective in the psbDII signal transduction pathway will not activate the psbDII promoter and hence will not express the codA gene and will survive on 5'-fluorocytosine, since they are unable to convert this substrate to 5-fluorouracil. These surviving colonies should carry a mutation in one component of the psbDII light-regulating pathway. The psbDII promoter was the promoter of choice for this gene fusion with which to test this strategy, since it had previously been well characterized and was known to be actively transcribed under both low- and high-light regimes (1, 4, 5). We describe here the basic design of the selection scheme together with the application of this scheme in the successful retrieval of mutations in the psbDII pathway.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Synechococcus strains
|
(Bethesda Research Laboratories, Inc., Gaithersburg, Md.) was used as the host for all plasmids and was propagated on Luria-Bertani broth (3) and Terrific Broth (13) media in the presence of antibiotics at standard concentrations (3).
Synechococcus species culture conditions.
For light-intensity experiments, cultures were grown in large petri dishes (150 x 15 mm) on a shaker at a constant temperature of 30°C in a lighted growth chamber. Light was provided by 20-W fluorescent tubes placed above the petri dishes. A light-sensitive probe (Biospherical Instruments, San Diego, Calif.) was used to measure the photosynthetic photon flux density, measured in µEm-2 s-1, reaching the cell cultures.
Construction of the psbDII-codA clone.
The pRTmcs-codA plasmid, which served as the starting vector for the construction of the psbDII-codA plasmid, was constructed as follows. The plasmid used for constructing pRTmcs-codA was pRT103, which was derived from pUC18/19 (15). In this plasmid, the cauliflower mosaic virus 35s promoter (cAMV-35s) and a plant polyadenylation site are located upstream and downstream, respectively, of the pUC18/19 multiple cloning site (15). The codA gene was amplified from E. coli by using PCR and cloned into the NcoI site of pRT103 to generate pRTmcs-codA (D. Morishige, personal communication).
A 256-bp fragment containing the -96 to + 160 region of the psbDII gene (1) was amplified by using PCR with Synechococcus species genomic DNA as the template. PCRs (25 µl each) contained the following: 100 ng of DNA, 1.5 mM MgCl2, approximately 0.04 to 0.07 µM (each) primer, 50 mM KCl, 10 mM Tris-HCl [pH 9.0], 0.1% Triton X-100, and 0.25 units of Taq DNA polymerase (Promega Corporation, Madison, Wis.). Primer sequences for the amplification of the psbDII 256-bp fragment are as follows: forward primer, 5'-GGAATTCGAAGCCTGCGAGACAC-3', and reverse primer, 5'-GACGTAAACCATCC-3'. Thirty cycles of amplification were performed as follows. Denaturation was at 92°C for 30 s, annealing of the primer to template DNA was performed at 45 to 50°C for 5 min, and elongation of the primer was at 72°C for 1 min. Reactions were carried out in a PCRExpress thermal cycler (Hybaid, Middlesex, United Kingdom). The amplified psbDII promoter fragment carried an EcoRI site on the 5' end (see the sequence of the forward primer in bold). The fragment was digested with EcoRI, purified, and then cloned into the EcoRI-SmaI digested plasmid pRTmcs-codA (a gift from D.T. Morishige, Department of Biochemistry, Texas A&M University). This cloning procedure generated an in-frame translational fusion between the psbDII promoter and the codA gene to generate pRTmcs-codA#5, where the promoter, ribosome binding site, and translational start site of the gene fusion comes from the psbDII gene. The identity of the pRTmcs-codA#5 clone was verified by DNA sequencing.
The entire fusion construct (psbDII-codA) was then excised from pRTmcs-codA#5 by digestion with XbaI and XhoI and ligated into XbaI- and XhoI-digested pAM1573 (2). pAM1573 is a neutral site II chromosomal integration vector developed in the laboratory of Susan Golden of Texas A&M University. This vector contains an E. coli origin of replication, a chloramphenicol cassette for the selection of recombinant E. coli and Synechococcus species transformants, and a multiple cloning site. Two fragments of the Synechococcus species chromosome termed neutral site II flank the antibiotic cassette and multiple cloning site. DNA constructs cloned between the two neutral site fragments will recombine into the Synechococcus species chromosome by a homologous recombination event. pAM1573 does not replicate in Synechococcus species, since it does not contain a Synechococcus species origin of replication and does not contain any Synechococcus species promoters (2). Cloning of the excised XhoI-XbaI fragment from pRT-mcs-codA into pAM1573 generated pAM1573 psbDII-codA. The pAM1573 psbDII-codA plasmid was transformed into Synechococcus strain AMC378, which carries a psbDII-lacZ fusion in chromosomal neutral site I (1), to give rise to strain DU201. A diagrammatic representation of the cloning of pAM1573 psbDII-codA is given in Fig. 1. Successful integration of the psbDII-codA construct into neutral site II of AMC378 was verified by PCR. This strain (DU201) was later used for chemical mutagenesis.
![]() View larger version (21K): [in a new window] |
FIG. 1. Diagrammatic representation of the cloning strategy used to generate S. elongatus strain DU201.
|
Mutagenesis protocol.
Chemical mutagenesis was carried out essentially as detailed in reference 8, with the following modifications. Cells (107) of strain DU201 were mixed with 1 mg of N-methyl-N'-nitro-N-nitrosoguanidine/ml in 50 ml of BG-11 medium for 30 min at 30°C with shaking. After being incubated, the cells were washed thoroughly two to three times with basal BG-11 medium and allowed to recover in liquid BG-11 medium without antibiotics for 6 days with shaking at a light intensity of 150 µE m-2 s-1 irradiance. The surviving cells were then plated onto BG-11 agar containing 0.5 mg of 5'-fluorocytosine/ml and allowed to grow at a light intensity of 150 µE m-2 s-1 irradiance. The colonies that grew on this medium were picked and restreaked onto BG-11 agar with 0.5 mg of 5'-fluorocytosine/ml. The colonies that grew after the second streaking were then inoculated into 100 ml of liquid BG-11 and allowed to grow with shaking at 150 µE m-2 s-1 irradiance until the cultures reached high cell density. Certain strains did not do well under this growth regime and, after two restreakings and inoculation into liquid BG-11, were then allowed to grow slowly without shaking at 150 µE m-2 s-1irradiance.
Plasmid preparation and DNA manipulations.
Plasmid preparation, subcloning, and other DNA manipulations were carried out as described in reference 3. All restriction enzymes were purchased from Promega Corporation (Madison, Wis.), unless stated otherwise. Laboratory reagents and chemicals used in ß-galactosidase assays were purchased from Sigma Corporation. All other laboratory reagents and chemicals were purchased from Fisher Scientific Inc.
ß-Galactosidase assays.
ß-Galactosidase assays were performed as described in reference 1.
|
|
|---|
A preliminary screening step to assay the effect of the mutations generated on psbDII promoter activity utilized the psbDII-lacZ construct in chromosomal neutral site I (1). In this step, ß-galactosidase assays were used to monitor the promoter activity of the psbDII gene. The ß-galactosidase levels would reflect the effect of a mutation that altered the psbDII promoter activity level in any of the isolates compared to that of the nonmutagenized control strain. This screening step separated those strains with mutations in the codA gene from those with mutations in the psbDII high-light pathway. Strains with mutations in the codA gene should show 5'-fluorocytosine resistance but have normal levels of psbDII activity. Strains that carried a mutation in the psbDII high-light pathway should show 5-fluorocytosine resistance and should also have altered psbDII promoter activity, as measured by ß-galactosidase levels, compared to that of the nonmutagenized DU201 control strain. Table 2 gives the distribution of different phenotypes for psbDII promoter activity retrieved after mutagenesis and selection with 5'-fluorocytosine-based selection criteria. The control strain used for comparison was nonmutagenized DU201.
|
View this table: [in a new window] |
TABLE 2. Phenotypes of isolated cyanobacterial mutant strains
|
![]() View larger version (22K): [in a new window] |
FIG. 2. Expression of psbDII-lacZ fusions in isolated mutant strains of S. elongatus. Specific activity (nanomoles of O-nitrophenyl-ß-D-galactopyranoside per minute per milligram of protein) was determined for each psbDII-lacZ reporter strain. ß-Galactosidase levels were corrected by subtracting background levels from a promoterless lacZ strain, AMC181. The graphed values represent the means of the results of triplicate experiments, with the standard deviations indicated. The histograms show ß-galactosidase levels for strain DU201 (control 1, control 2, and control 3) with mutant strains U, Z, JU4, J, and K 0 h before (hatched bars) and 2 h after (black bars) the shift to high light (800 µE m-2 s-1). The graphed values for the data for control 1, control 2, and mutants U, Z, and JU4 are the means of the results of triplicate independent experiments, with the standard deviations indicated. The data for control 3 and mutant strains J and K were from one experiment. Due to the poor growth of strains J and K in high light, it was difficult to repeat the experiments.
|
Three mutants, mutants J, K, and Z, also showed impaired growth rates. These mutants were initially isolated without shaking in liquid culture. As seen in Fig. 3, all three mutants had lower growth rates when grown under high-light intensity in liquid culture than that of control strain DU201. In particular, mutant Z could not be grown under high-light conditions, as this strain rapidly bleached and died under these conditions. Thus, no ß-galactosidase values were obtained for this strain.
![]() View larger version (16K): [in a new window] |
FIG. 3. Growth curve for control strain DU201 and selected mutant strains under high-light conditions. The following symbols represent the indicated strains: , strain DU201; , strain K; , strain J; and , strain Z. OD750, optical density at 750 nm.
|
|
|
|---|
In this study, mutations were created by treatment of strain DU201 with the chemical agent MMNG (8). However, this scheme lends itself to use with a variety of mutagenic strategies and agents. Mutations can as easily be created by transposon or interposon mutagenesis. A scheme for these types of mutagenesis in Synechococcus species has recently been designed and would be appropriate for use with this selection strategy (2). In particular, this strategy is useful where a visible or easily identifiable mutant phenotype is not available for purposes of selection. This screen uses resistance to 5'-fluorocytosine as the phenotypic selection criterion for mutant identification.
It was anticipated that this selection scheme would give rise to cells with decreased psbDII promoter activity in high light. However, we isolated five independent mutant strains that showed elevated psbDII activity in low and high light, which implies that these strains also produce elevated levels of cytosine deaminase. If this were indeed the case, these mutants would not have been isolated as viable colonies by this selection method. It is very likely that these mutants possess a secondary mutation in the codA gene that obliterates cytosine deaminase function, thereby conferring a 5'-fluorocytosine-resistant phenotype on these cells that allowed them to be isolated in this screen. Identification of strains with secondary mutations in the codA gene could be carried out by replacing the lacZ gene in neutral site I with a second copy of the psbDII-codA construct, which would cause these strains to be sensitive to 5'-fluorocytosine. With replica plating on medium without the selective agent, the strains could be kept viable, while at the same time the second site mutation in the codA gene could be confirmed. This strategy would then also allow for the isolation of mutations in the signal transduction pathway that confer elevated levels of expression of the target gene.
The mutants isolated by this approach that have presently been characterized had impaired function of the target gene, psbDII. Mutants J, K, Z, JU4, and U all had psbDII promoter activities that differed significantly from those of the wild type. Previous studies with the psbDII promoter have shown that a mutation in binding site 1 negates high-light induction of psbDII, while mutations in binding sites 2 and 3 affect positive and negative regulatory elements, respectively (1). Thus, mutants J and K should have mutations in the protein factor that binds to binding site 1, while mutants Z and JU4 should have abnormal protein factors that bind to binding site 2 (1). It is anticipated that mutant U is aberrant for the protein factor binding to binding site 3 or to the direct repeat region within the psbDII open reading frame (1).
In addition, mutants J and K, which showed no high-light induction of the psbDII promoter, also showed aberrant growth rates in high light. It has been demonstrated that loss of psbDII function, while not lethal in Synechococcus species, causes the organism to be less competitive than the wild type in mixed-culture experiments (5). Thus, these mutants show phenotypes similar to that of the previously reported psbDII-null mutant. It has been demonstrated by gel shift analysis that the upstream regions of the psbDII, psbAII, and psbAIII genes bind the same trans-acting factors (4). It is possible that mutations in one or more of these protein factors could have a pleiotropic effect, affecting not only expression of the psbDII gene but also expression of other high-light-inducible genes like psbAII and psbAIII in Synechococcus species. This effect could account for the low growth rate and defects in pigmentation seen in isolates J and K.
Rescue of these mutations with genomic DNA allows us to precisely pinpoint the site of the mutations and to identify those genes that are part of the psbDII high-light pathway. Rescue of the mutations, however, confers wild-type regulation on the psbDII promoter, which in turn leads to expression of the codA gene and death of the rescued mutant on 5'-fluorocytosine. To overcome this problem, rescued mutants should be replica-plated on medium with and without 5'-fluorocytosine after transformation with genomic DNA to obtain viable rescued cells. Indeed, the sensitivity of the rescued strains to 5'-fluorocytosine can be used as an indication that a successful rescue of the mutant phenotype has taken place with the consequent reconstitution of the wild-type signal transduction pathway.
The psbDII promoter used in this selection method is active under both conditions tested, i.e., low- and high-light intensities. Since our goal was to isolate mutants that were affected by both the low- and high-light expression of this gene, this characteristic of the promoter was crucial for our outcome. The choice of promoter to be used in this selection scheme can greatly influence the outcome of the mutants isolated. A promoter that is tightly regulated in a temporal or cell-specific manner can also be used with this selection scheme, and the expression window of the promoter can be utilized to select for mutants that are aberrant in either temporal or cell-specific regulation of the signal transduction pathway under analysis. Indeed, the utility of this selection method can be extended by using an inducible promoter-operator system like lacI-lacZ to control the expression of the codA gene in a time- or cell-specific manner for the isolation of mutants defective in either temporal or cell-specific expression of the signaling pathway under study.
The ability to generate and screen random mutations is a crucial step in isolating the components and understanding the functioning of a signal transduction pathway (6, 11). We have described a genetic selection scheme that lends itself to the isolation of mutants defective in a cellular signal transduction pathway where the resulting viable colonies are mutant, thus allowing for easy selection of mutant phenotypes. Identification of the mutated loci could be done by transformation of the mutant with a genomic library and scoring for rescue of the mutant phenotype (8). If mutagenesis were by a transposon, then isolation of the transposon would indicate the mutated locus of the gene (2). This selection scheme is easy to carry out once the codA construct is generated and can be used in systems where an intrinsic codA gene is absent or where the native codA gene has been deleted. The genetic selection scheme described here extends the tools available for the isolation and characterization of mutations in a given signal transduction pathway.
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»